Laurence Collette

机构：GlaxoSmithKline (Belgium) · ORCID：0000-0003-2518-7281

发表论文 433 篇 · 总被引 49786 次 · h-index 99

代表论文

• Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation (2020 · The Lancet Oncology · 被引 1116)
• Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group (2021 · Radiotherapy and Oncology · 被引 392)
• International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium (2020 · The Lancet Oncology · 被引 325)
• Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium (2021 · Journal of Clinical Oncology · 被引 252)
• Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium (2021 · Journal of Clinical Oncology · 被引 178)
• Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials (2021 · European Urology · 被引 138)